New guidelines issued for hypercholesterolemia management in adults over 75

The National Lipid Association (NLA) and American Geriatrics Society (AGS) have published a joint scientific statement that focus on the treatment of hypercholesterolemia in adults over 75 years of age, which do not have atherosclerotic cardiovascular disease (ASCVD) in the past. Published WI, this common effort, developed by a diverse team of clinical lipidologists, cardiologists, geriatrics and pharmacists, offers guidelines based on evidence to help clinicians move on the complexity of cholesterol management in the growing population of older people.

Older people have many competitive medical and social needs, so treating high cholesterol in people without cardiovascular diseases can not always be easy for clinicists and patients. We hope that it will help to ensure as much clarity as possible. “

Vera Bittner, MD, MSPH, MNLA, co -chairman of the scientific declaration

In the statement, he reviews current evidence regarding the therapy that reduces lipids in the elderly without established ASCVD and offers pragmatic recommendations for supporting clinical decisions in this unique population.

“AGS is excited that it has adapted our NLA efforts to ensure that lipid management for adults over 75 years of age is personalized, based on evidence and careful various needs of our aging population,” Sunny Linnebur, Pharmd, co-chairing this statement.

Since the US population is constantly getting old, the number of people over 75 lives without a diagnosed cardiovascular disease. However, the decision to initiate or continue therapy that reduces cholesterol in these patients may be a challenge due to limited clinical trial data, the presence of comorbidities, polypharma and various care goals.

This statement serves as a key resource, which has conducted personalized decisions on the treatment of potential benefits in preventing ASCVD with reality of aging and ending life, fragility, drug loads and patient preferences.